Chemistry laboratories are comfortable places for reactions that would be disastrous inside a living cell. Reagents can be harsh, solvents can be toxic, and many useful reactions interfere with the molecules that keep an organism alive. Carolyn Bertozzi helped develop an alternative: chemistry that can take place in a biological system while largely avoiding unwanted reactions with its ordinary components.
Her work would eventually become known as bioorthogonal chemistry, a scientific toolkit that changed how researchers observe living cells, label biological molecules and develop new approaches to molecular medicine. In 2022, this pioneering contribution earned Bertozzi a share of the Nobel Prize in Chemistry.
The Challenge of Doing Chemistry Inside Living Cells
Traditional chemical synthesis often depends on conditions that living systems cannot tolerate. Strong reagents, reactive intermediates and certain metal catalysts may work well in a flask but damage proteins, membranes and other essential components of a cell.
For researchers interested in studying biological molecules in their natural environment, this created a fundamental problem. Removing a molecule from a cell could make it easier to analyze, but that separation could also remove the context in which the molecule performed its function.
Bertozzi helped develop a different approach. Rather than forcing biological systems to accommodate conventional laboratory chemistry, her research explored reactions specifically selected to work within living environments.
The central principle was selectivity. Researchers could introduce two compatible chemical groups that would recognize and react with each other while largely avoiding interference with the many other molecules present in cells.
This approach came to be known as bioorthogonal chemistry. Its significance was not simply the formation of a new chemical bond. It was the possibility of carrying out that transformation in a place where conventional chemical reactions could cause extensive disruption.
A Search for Cell-Surface Sugars Led to a New Chemistry
Bertozzi’s work grew out of a question about glycans, the complex sugar structures that decorate cell surfaces and participate in biological recognition and communication.
Glycans are involved in processes ranging from cellular interactions to immune responses. Yet they can be difficult to study because of their structural complexity and the challenges of tracking them in living systems.
Conventional analytical methods often required isolating biological molecules from their surroundings. Bertozzi and her colleagues wanted to observe glycans while cells remained alive, preserving the biological environment in which those molecules operated.
The researchers explored ways to introduce small chemical handles into sugar molecules that cells could incorporate into their surface glycans. Those handles could then react with a second chemical component carrying a detectable label.
One important breakthrough emerged from a modified version of the Staudinger reaction. In 2000, Ellen Saxon and Bertozzi reported a strategy that allowed specially introduced chemical groups to form a stable connection under conditions compatible with biological research.
The resulting approach, known as Staudinger ligation, provided an early demonstration that researchers could attach labels to molecules associated with living cells without relying on broadly reactive chemistry.
The ability to observe glycans in their biological setting helped open a broader field. Instead of studying only isolated molecular structures, scientists could increasingly investigate the location and behavior of selected molecules in living systems.
Why Copper-Free Click Chemistry Became a Turning Point
Another important development came from click chemistry, an approach associated with reliable reactions that join molecular components efficiently and selectively.
Among the most influential examples was copper-catalyzed azide-alkyne cycloaddition, developed independently by researchers working with K. Barry Sharpless and Morten Meldal.
The reaction was exceptionally useful for connecting molecular building blocks. However, copper catalysts could create problems when researchers attempted to use this chemistry in sensitive living systems.
Bertozzi and colleagues developed a way around this limitation. In 2004, her group reported a copper-free approach using a strained cyclic alkyne to promote a reaction with an azide.
This method, known as strain-promoted azide-alkyne cycloaddition, made it possible to perform another class of selective chemical labeling reactions without depending on a copper catalyst.
The advance mattered because biological compatibility is not merely a convenient feature. For many experiments, it determines whether a reaction can be used at all.
Bioorthogonal methods provided scientists with new ways to tag molecules, monitor their distribution and investigate how biological components behave over time.
These techniques were not universal solutions. Reaction rates, stability, delivery and unwanted interactions still required careful optimization. Nevertheless, the conceptual breakthrough expanded the range of chemistry researchers could attempt in biological environments.
The 2022 Nobel Prize Recognized a New Molecular Toolkit
On October 5, 2022, the Royal Swedish Academy of Sciences announced that Carolyn Bertozzi, Morten Meldal and K. Barry Sharpless would share the Nobel Prize in Chemistry for the development of click chemistry and bioorthogonal chemistry.
The three scientists received equal shares of the prize, reflecting complementary contributions to chemical methods that had become influential across multiple scientific disciplines.
Sharpless and Meldal helped establish powerful approaches for connecting molecular building blocks through click reactions. Bertozzi extended the possibilities by developing chemical transformations suitable for studying molecules in living biological systems.
The distinction is scientifically important. A reaction that works efficiently in a laboratory flask may not be suitable for use within a living cell. Bioorthogonal chemistry addresses that additional challenge by selecting reactions that can proceed in complex biological environments without substantially disrupting ordinary cellular chemistry.
The Nobel recognized more than an individual reaction. It acknowledged a broader transformation in how chemists interact with biological systems and investigate molecular processes.
How Bioorthogonal Chemistry Influenced Peptide and Drug Design
Bioorthogonal chemistry is not synonymous with peptide therapeutics, but its influence reaches deeply into modern biotechnology and molecular drug development.
Researchers often need to attach one molecular component to another without modifying unrelated parts of a complex biological system. This is especially relevant when working with proteins, peptides, imaging agents and delivery technologies.
Selective conjugation methods can help scientists connect detectable labels to biological molecules, study their behavior or investigate how different chemical modifications affect biological activity.
In peptide research, such methods can support the development of molecular probes and chemically modified constructs. Researchers may also investigate ways to combine biological targeting components with diagnostic or therapeutic payloads.
The broader field of bioconjugation has benefited from reactions that offer reliable control over where molecular components are connected. That control can be valuable when scientists want to preserve the function of a biological molecule while introducing an additional feature.
Bertozzi’s research has also contributed to approaches for studying disease-associated cell-surface chemistry and developing new diagnostic and therapeutic strategies.
However, the distinction between laboratory capability and clinical success remains essential. A selective reaction may be useful in research without producing a safe or effective medicine.
Drug candidates still require evidence of appropriate distribution, safety, biological activity, manufacturing consistency and clinical benefit. Bioorthogonal chemistry provides a set of tools for constructing and studying molecules; it does not eliminate the difficult process of therapeutic development.
The Lasting Legacy: Making Chemistry Adapt to Biology
Carolyn Bertozzi’s career illustrates why foundational scientific methods can matter long before their eventual applications become clear.
The original questions concerned the behavior of complex sugar molecules on living cells. The resulting chemistry became useful across a much wider scientific landscape, including molecular imaging, diagnostics, biological labeling and experimental approaches to drug development.
This is a familiar pattern in the history of scientific progress. A new experimental method can transform what researchers are able to observe, measure and construct, even when it does not immediately produce a commercial medicine.
The ability to follow a molecule within a living cell changes the questions scientists can ask about its behavior. The ability to attach a chemical component selectively changes the kinds of molecular systems researchers can build.
Those possibilities have helped shape the relationship between chemistry, biology and medicine. They have also provided researchers with methods that continue to evolve as new applications and technical limitations emerge.
The enduring contribution of Bertozzi and her collaborators is a change in the rules of engagement between chemistry and living systems.
Rather than forcing biology into the conditions of a traditional chemistry laboratory, their work helped establish ways for chemistry to operate within biological environments.
That shift remains a powerful idea in modern molecular science. The most significant breakthrough was not necessarily a particular drug or diagnostic product, but a method that made new scientific questions experimentally accessible.
Sometimes the molecules that change medicine begin with a more fundamental achievement: discovering how to make the right chemical bond without disturbing everything around it.
Sources and Further Reading
- The Nobel Prize in Chemistry 2022 — Official Nobel Prize Record
- Stanford University — Carolyn Bertozzi Wins Nobel in Chemistry
- Stanford Chemistry — Carolyn Bertozzi Awarded Nobel Prize
- Saxon and Bertozzi (2000) — Cell Surface Engineering by a Modified Staudinger Reaction
- Agard, Prescher and Bertozzi (2004) — Strain-Promoted Azide-Alkyne Cycloaddition
